Search Results for: Catalyst Biosciences Receives Two Milestone
Articles
March 27, 2018
Catalyst Biosciences Receives Two Milestone Payments March 27, 2018
Catalyst Biosciences, Inc. recently announced it has received $1.5 million in milestone payments following the completion of two triggering events...
June 29, 2021
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency June 29, 2021
Catalyst Biosciences, Inc. recently announced the US FDA has granted Fast Track Designation for Marzeptacog alfa (activated), MarzAA, the company’s...
